Director HTA, Value & Evidence
Pfizer Pharma GmbH, Germany
Disclosure(s): Pfizer: Employee, Stocks/Bonds (Public Company)
Dr. Katharina Schley, Director Value & Evidence, Pfizer Pharma GmbH, Berlin, Germany.
Analytical, data-oriented and creative health economist with strategic mind and strong academic background in outcome research, including handling of databases, statistical analysis, project management and track record of publications with experience in HEOR projects and recommendation and reimbursement processes for vaccines both in Germany and the US as well as on global level to benefit patients world-wide.